Trial intelligence / Profile preview

Mechanical Thrombectomy in M2 MCA Occlusion

NCT05091320Phase 3Unknown

Sponsor
Assiut University
Start
Dec 2021
Primary completion
Nov 2022
01

Overview

Phase 3, randomised, open-label trial in ischemic stroke (2 arms), sponsored by Assiut University. Primary endpoint: Clinical neurological outcome at 3 months. Status: unknown.

02

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT05091320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05091320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call